Tag: Pfizer

Discover vital market insights and social media trends affecting investments on September 30, 2024.

Explore the latest market trends and social media signals that could influence your investments.

Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.

ArborXR raises $12M to enhance XR training and device management, aiding global enterprises in adopting immersive technologies.

ArborXR raised $12M to expand its platform for managing AR and VR devices, focusing on enterprise and educational markets.

Explore promising biotech stocks like Vertex, Pfizer, and Merck, ready to innovate and grow in the evolving healthcare landscape.

Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.

Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...

Income seekers can find high-yielding dividend stocks, despite challenges faced by IIP. The COVID-19 pandemic disrupted plans, but coal companies ...

Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...